CYMBF yields 3.06% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CYMBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CYMBF + PFE for your $10,000?
Cymbria Corporation is a closed ended equity fund launched and managed by EdgePoint Investment Group Inc. The fund invests in the public equity markets across the globe. It also invests some portion of its portfolio in derivative instruments, privately held businesses or leverage its investments. The fund holds a substantial amount of investment in EdgePoint Wealth Management. Inc. It invests in the stocks of companies operating across diversified sectors. The fund invests in the value stocks of companies across all market capitalizations. It focuses on factors like proprietary insights, long term views, focus on growth, extensive research, incisive analysis, and assessment of value sums up to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index (C$). Cymbria Corporation was formed on September 4, 2008 and is domiciled in Canada.
Full CYMBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.